Pavel G. Yakovlev

Ukraine

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

CLINICAL CASE OF COMPLEX RADICAL TREATMENT OF METASTATIC PROGRESSION TO RARE SITE OF PRIMARY ORGAN CONFINED CHROMOPHOBE RENAL CELL CARCINOMA TREATED WITH LAPAROSCOPIC PARTIAL NEPHRECTOMY.

CLINICAL CASE OF COMPLEX RADICAL TREATMENT OF METASTATIC PROGRESSION TO RARE SITE OF PRIMARY ORGAN CONFINED CHROMOPHOBE RENAL CELL CARCINOMA TREATED WITH LAPAROSCOPIC PARTIAL NEPHRECTOMY.

Journal: Experimental oncology
Published: March 05, 2026

Quality of Life Assessed by the Questionnaire MOS SF-36 in Bladder Cancer Patients Depending on the Method of Surgical Treatment.

Quality of Life Assessed by the Questionnaire MOS SF-36 in Bladder Cancer Patients Depending on the Method of Surgical Treatment.

Journal: Experimental oncology
Published: February 20, 2025

Evaluation of proteolytic activity and serine proteases distribution in plasma from patients with bladder cancer.

Evaluation of proteolytic activity and serine proteases distribution in plasma from patients with bladder cancer.

Journal: Frontiers in medicine
Published: August 13, 2023

COMPARISON OF 2D AND 3D PRIMARY CELL CULTURES OBTAINED FROM EXPLANT OF HIGH-GRADE UROTHELIAL BLADDER CANCER.

COMPARISON OF 2D AND 3D PRIMARY CELL CULTURES OBTAINED FROM EXPLANT OF HIGH-GRADE UROTHELIAL BLADDER CANCER.

Journal: Experimental oncology
Published: June 26, 2023

Expression of TLR4 and major inflammatory cytokines in patients with bladder cancer of different grade and stage.

Expression of TLR4 and major inflammatory cytokines in patients with bladder cancer of different grade and stage.

Journal: Experimental oncology
Published: June 30, 2021

Changes in expression of TLR-4, TGF-β, INF-γ, TNF-α in cultured T24/83 cells of invasive bladder cancer treated with cisplatin and/or polyphenolic adjuvant melanin.

Changes in expression of TLR-4, TGF-β, INF-γ, TNF-α in cultured T24/83 cells of invasive bladder cancer treated with cisplatin and/or polyphenolic adjuvant melanin.

Journal: Experimental oncology
Published: March 31, 2021

Bladder sparing surgery in high-grade bladder cancer.

Bladder sparing surgery in high-grade bladder cancer.

Journal: Experimental oncology
Published: July 03, 2019

Lymphocyte count in peripheral blood is a sensitive tool in pretreatment assessment of patients with urological cancer.

Lymphocyte count in peripheral blood is a sensitive tool in pretreatment assessment of patients with urological cancer.

Journal: Experimental oncology
Published: June 28, 2018

Adjuvant recMAGE-A3 Immunotherapy After Cystectomy for Muscle-invasive Bladder Cancer: Lessons Learned from the Phase 2 MAGNOLIA Clinical Trial.

Adjuvant recMAGE-A3 Immunotherapy After Cystectomy for Muscle-invasive Bladder Cancer: Lessons Learned from the Phase 2 MAGNOLIA Clinical Trial.

Journal: European urology focus
Published: December 08, 2017

Effect of androgen suppression on bone mineral density in patients with prostate cancer.

Effect of androgen suppression on bone mineral density in patients with prostate cancer.

Journal: Experimental oncology
Published: December 25, 2014

Perioperative chemotherapy in muscle-invasive bladder cancer: overview and the unmet clinical need for alternative adjuvant therapy as studied in the MAGNOLIA trial.

Perioperative chemotherapy in muscle-invasive bladder cancer: overview and the unmet clinical need for alternative adjuvant therapy as studied in the MAGNOLIA trial.

Journal: European urology
Published: October 21, 2013
Showing 1-11 of 11

Last Updated: 09/26/2026